dc.contributor.author | Ostensen, Monika | |
dc.contributor.author | Khamashta, Munther | |
dc.contributor.author | Lockshin, Michael | |
dc.contributor.author | Parke, Ann | |
dc.contributor.author | Brucato, Antonio | |
dc.contributor.author | Carp, Howard | |
dc.contributor.author | Doria, Andrea | |
dc.contributor.author | Rai, Raj | |
dc.contributor.author | Meroni, Pierluigi | |
dc.contributor.author | Cetin, Irene | |
dc.contributor.author | Derksen, Ronald | |
dc.contributor.author | Branch, Ware | |
dc.contributor.author | Motta, Mario | |
dc.contributor.author | Gordon, Caroline | |
dc.contributor.author | Ruiz Irastorza, Guillermo | |
dc.contributor.author | Spinillo, Arsenio | |
dc.contributor.author | Friedman, Deborah | |
dc.contributor.author | Cimaz, Rolando | |
dc.contributor.author | Czeizel, Andrew | |
dc.contributor.author | Piette, Charles Piette | |
dc.contributor.author | Cervera, Ricard | |
dc.contributor.author | Levy, Roger A. | |
dc.contributor.author | Clementi, Maurizio | |
dc.contributor.author | De Carolis, Sara | |
dc.contributor.author | Petri, Michelle | |
dc.contributor.author | Shoenfeld, Yehuda | |
dc.contributor.author | Faden, David | |
dc.contributor.author | Valesini, Guido | |
dc.contributor.author | Tincani, Angela | |
dc.date.accessioned | 2019-04-17T11:30:52Z | |
dc.date.available | 2019-04-17T11:30:52Z | |
dc.date.issued | 2006-05-11 | |
dc.identifier.citation | Arthritis Research & Therapy 8 : (2006) // Article ID 209 | es_ES |
dc.identifier.issn | 1478-6354 | |
dc.identifier.uri | http://hdl.handle.net/10810/32537 | |
dc.description.abstract | Rheumatic diseases in women of childbearing years may necessitate drug treatment during a pregnancy, to control maternal disease activity and to ensure a successful pregnancy outcome. This survey is based on a consensus workshop of international experts discussing effects of anti-inflammatory, immunosuppressive and biological drugs during pregnancy and lactation. In addition, effects of these drugs on male and female fertility and possible long-term effects on infants exposed to drugs antenatally are discussed where data were available. Recommendations for drug treatment during pregnancy and lactation are given. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Biomed Central | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | inflammatory-bowel-disease | es_ES |
dc.subject | systemic-lupus-erythematosus | es_ES |
dc.subject | low-dose methotrexate | es_ES |
dc.subject | fetal ductus-arteriosus | es_ES |
dc.subject | 1st trimester exposure | es_ES |
dc.subject | induced congenital malformations | es_ES |
dc.subject | kidney-transplant recipients | es_ES |
dc.subject | single centers experience | es_ES |
dc.subject | human-breast milk | es_ES |
dc.subject | in-utero | es_ES |
dc.title | Anti-Inflammatory and Immunosuppressive Drugs and Reproduction | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://arthritis-research.biomedcentral.com/articles/10.1186/ar1957 | es_ES |
dc.identifier.doi | 10.1186/ar1957 | |
dc.departamentoes | Medicina | es_ES |
dc.departamentoeu | Medikuntza | es_ES |